Aizen Therapeutics Signs Oral Peptide Collaboration
Aug 17, 2026
Biotech
EpiVax Adds AI Models to ISPRI Immunogenicity Platform
September 02, 2026
EpiVax released AI enhancements for ISPRI, including JanusMatrix 2.1, a JAX immunogenicity score, and ADA 2.2 for antibody immunogenicity risk assessment.
EpiVax has released AI enhancements to ISPRI, its in silico platform for assessing immunogenicity risk in biotherapeutics, the company announced in a press release.
The update includes JanusMatrix 2.1, which applies AI to improve immune tolerance prediction by weighting human epitope cross conservation with expression and prevalence data. ISPRI already combines EpiMatrix and JanusMatrix to evaluate T cell epitope content and human cross conservation in therapeutic sequences.
EpiVax also added the JAX score, which incorporates JanusMatrix tolerance potential into EpiMatrix scores. The company said the score is designed to align more closely with clinical immunogenicity outcomes.
The release also includes ADA 2.2, an updated model for antibody immunogenicity risk. ADA 2.2 combines measures based on epitopes with biophysical attributes and mode of action criteria, and was trained using clinical monoclonal antibody data.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
09/02
Onymos and Vanta Diagnostics Report AI Lab Intake Results
09/02
Konko AI Raises $6 Million for Patient Journey Platform
09/02
World Class Health Introduces AI Specialty Clinic
09/02
nference and Rush Plan Clinical Analytics Platform for Research
09/02
Thyme Care Raises Over $125 Million and Forms Thyme Companies
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more